⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ENSC News
Ensysce Biosciences, Inc. Common Stock
Ensysce Biosciences Secures IRB Approval of Final Phase of PF614-MPAR-102 Clinical Study
accessnewswire.com
ENSC
Form 8-K
sec.gov
ENSCW
ENSC
Ensysce Biosciences Secures Second Financing From 2025 Agreement to Advance Breakthrough Pain Programs
accessnewswire.com
ENSC
Form 8-K
sec.gov
ENSCW
ENSC
Form 8-K
sec.gov
ENSC
ENSCW
Ensysce Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results
accessnewswire.com
ENSC
Form 8-K
sec.gov
ENSC
ENSCW
Form 8-K
sec.gov
ENSC
ENSCW
Ensysce Biosciences Initiates Live "Ask Me Anything" (AMA) Session Highlighting Growth and Future Plans
accessnewswire.com
ENSC
Ensysce Biosciences Announces First Peer-Reviewed Clinical Publication Demonstrating Oral Overdose Protection with MPAR(R) Technology
accessnewswire.com
ENSC